Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
29 hedge funds and large institutions have $38.2M invested in Vaxxinity, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.
567% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 3
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
142% more funds holding
Funds holding: 12 → 29 (+17)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less capital invested
Capital invested by funds: $76.6M → $38.2M (-$38.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$12.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.58M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$2.35M |
| 4 |
ECM
Element Capital Management
New York
|
+$1.42M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PML
Prime Movers Lab
Jackson,
Wyoming
|
-$677K |
| 2 |
Goldman Sachs
New York
|
-$417K |
| 3 |
HF
HRT Financial
New York
|
-$73K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWS
26
Glassman Wealth Services
Vienna,
Virginia
| $4K | +$9.02K | +2,386 | New |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$3.78K | +1,000 | New |
|
28
Citigroup
New York
| $2K | +$5.47K | +1,447 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | +$4.51K | +1,193 | New |
|
|
30
Goldman Sachs
New York
| – | -$417K | -97,069 | Closed |
|
|
HF
31
HRT Financial
New York
| – | -$73K | -17,090 | Closed |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$46K | -10,766 | Closed |
|
VAXX Hedge Fund Activity: Q2 2022 in Review
29 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2022, worth a combined $38.2M — down 50% from $76.6M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VAXX positions and 3 closed out — a net gain of 17 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Bank of America, adding an estimated $12.1M. The largest seller was Prime Movers Lab, cutting an estimated $677K.
- 29 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $38.2M of Vaxxinity, Inc. Class A Common Stock stock for Q2 2022, down 50% quarter-over-quarter.
- 20 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2022 and 3 closed out, a net change of +17 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2022 was Bank of America, an estimated $12.1M added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2022 was Prime Movers Lab, an estimated $677K sold.
Based on aggregated 13F filings for Q2 2022.